ALT
Altimmune, Inc.
Company overview
- Market capitalization
- $575.77M
- Employees
- 57
- Latest publication
- 2026-09-29
About Altimmune, Inc.
Altimmune, Inc., a late clinical stage biopharmaceutical company, focuses on developing novel therapies for serious liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis, alcohol use disorder, and alcohol-associated liver disease. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Research Development | 18,655,000USD | 16,169,000USD | 18,409,000USD | 14,960,000USD | 17,236,000USD | 15,827,000USD | 19,781,000USD | 19,803,000USD |
| Total Operating Expenses | 26,229,000USD | 24,221,000USD | 28,919,000USD | 5,904,000USD | 22,927,000USD | 21,820,000USD | 24,871,000USD | 24,772,000USD |
| Net Income | -22,825,000USD | -22,563,000USD | -27,358,000USD | -19,014,000USD | -22,146,000USD | -19,575,000USD | -23,180,000USD | -22,845,000USD |
| Total Revenue | — | 0USD | 26,000USD | 5,000USD | 5,000USD | 5,000USD | 5,000USD | 5,000USD |
| Cost Of Revenue | — | 23,000USD | 26,000USD | 14,960,000USD | 30,000USD | — | 33,000USD | 37,000USD |
| Gross Profit | — | -23,000USD | 26,000USD | -14,955,000USD | 5,000USD | 5,000USD | 5,000USD | 5,000USD |
| Selling General Administrative | — | 8,052,000USD | 10,510,000USD | 5,904,000USD | 5,691,000USD | 5,993,000USD | 5,090,000USD | 4,969,000USD |
| Operating Income | — | -24,244,000USD | -28,893,000USD | -20,859,000USD | -22,922,000USD | -21,815,000USD | -24,866,000USD | -24,767,000USD |
| Interest Income | — | 2,901,000USD | 2,438,000USD | 2,426,000USD | 1,132,000USD | 1,545,000USD | 1,569,000USD | 1,910,000USD |
| Interest Expense | — | 1,068,000USD | 876,000USD | 495,000USD | 264,000USD | 1,000USD | 1,000USD | 6,000USD |
| Net Interest Income | — | 1,833,000USD | 1,562,000USD | 1,931,000USD | 868,000USD | 1,544,000USD | 1,568,000USD | 1,904,000USD |
| Income Before Tax | — | -22,563,000USD | -27,358,000USD | -19,014,000USD | -22,146,000USD | -20,256,000USD | -23,180,000USD | -22,845,000USD |
| Tax Provision | — | 0USD | 0USD | 0USD | 0USD | -681,000USD | — | 0USD |
| Net Income From Continuing Ops | — | -22,563,000USD | -27,358,000USD | -19,014,000USD | -22,146,000USD | -19,575,000USD | -23,180,000USD | -22,845,000USD |
| Ebit | — | -24,244,000USD | -28,919,000USD | -18,519,000USD | -21,882,000USD | -20,255,000USD | -23,179,000USD | -22,839,000USD |
| Ebitda | — | -24,221,000USD | -28,893,000USD | -18,492,000USD | -21,852,000USD | -20,226,000USD | -23,146,000USD | -22,802,000USD |
| Depreciation And Amortization | — | 23,000USD | 26,000USD | 27,000USD | 30,000USD | 29,000USD | 33,000USD | 37,000USD |
| Reconciled Depreciation | — | 23,000USD | 26,000USD | 27,000USD | 30,000USD | 29,000USD | 33,000USD | 37,000USD |
| Total Other Income Expense Net | — | 1,681,000USD | 1,535,000USD | 1,845,000USD | 776,000USD | 1,559,000USD | 1,686,000USD | 1,922,000USD |
| Unclassified Operating Expenses | — | — | — | -14,960,000USD | — | — | — | — |
| Income Tax Expense | — | — | — | — | — | -681,000USD | — | — |
| Selling And Marketing Expenses | — | — | — | — | — | — | 107,000USD | — |
| Source | DisclosurePreliminary | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 41,000USD | 20,000USD | 426,000USD | -68,000USD | 4,410,000USD | 8,185,027USD | 5,801,401USD | 10,331,168USD |
| Cost Of Revenue | 112,000USD | 238,000USD | 477,000USD | 500,000USD | 73,841,000USD | 33,509,318USD | 17,065,553USD | 18,459,310USD |
| Gross Profit | 41,000USD | 20,000USD | 426,000USD | -68,000USD | 4,410,000USD | -25,324,291USD | 5,801,401USD | -8,128,142USD |
| Research Development | 66,432,000USD | 82,226,000USD | 65,799,000USD | 70,538,000USD | 74,541,000USD | 49,774,328USD | 17,765,553USD | 18,459,310USD |
| Selling General Administrative | 28,098,000USD | 20,966,000USD | 18,137,000USD | 17,134,000USD | 15,413,000USD | 13,209,440USD | 8,500,783USD | 9,765,581USD |
| Total Operating Expenses | 94,530,000USD | 103,192,000USD | 96,355,000USD | 87,672,000USD | 101,324,000USD | 29,474,450USD | 27,266,336USD | 28,224,891USD |
| Operating Income | -94,489,000USD | -103,172,000USD | -95,929,000USD | -87,740,000USD | -96,914,000USD | -54,798,741USD | -21,464,935USD | -42,834,410USD |
| Interest Income | 7,541,000USD | 8,074,000USD | 7,351,000USD | 2,870,000USD | 202,741USD | 322,514USD | 843,409USD | 226,597USD |
| Interest Expense | 1,636,000USD | 9,000USD | 35,000USD | 8,000USD | 5,000USD | 9,421USD | 2,244USD | 297,090USD |
| Net Interest Income | 5,905,000USD | 8,065,000USD | 7,316,000USD | 2,862,000USD | 197,085USD | 313,093USD | 841,165USD | -70,493USD |
| Income Before Tax | -88,774,000USD | -95,059,000USD | -88,447,000USD | -84,910,000USD | -97,090,000USD | -43,627,454USD | -20,578,631USD | -45,320,946USD |
| Income Tax Expense | -681,000USD | — | 309,105USD | -197,000USD | -919,513USD | 5,417,023USD | -58,500USD | -6,149,794USD |
| Tax Provision | -681,000USD | 0USD | 0USD | -197,000USD | -110,346USD | -5,417,024USD | -58,500USD | -6,149,794USD |
| Net Income | -88,093,000USD | -95,059,000USD | -88,447,000USD | -84,713,000USD | -97,090,000USD | -49,044,477USD | -20,520,131USD | -39,171,152USD |
| Net Income From Continuing Ops | -88,093,000USD | -95,059,000USD | -88,447,000USD | -84,713,000USD | -97,090,824USD | -49,044,477USD | -20,520,131USD | -39,171,152USD |
| Ebit | -87,138,000USD | -95,050,000USD | -88,412,000USD | -84,902,000USD | -97,085,000USD | -38,533,731USD | -20,576,387USD | -45,023,852USD |
| Ebitda | -87,026,000USD | -94,812,000USD | -87,935,000USD | -84,409,000USD | -96,534,000USD | -38,104,853USD | -20,189,066USD | -44,721,483USD |
| Depreciation And Amortization | 112,000USD | 238,000USD | 477,000USD | 493,000USD | 551,000USD | 428,878USD | 387,321USD | 302,369USD |
| Reconciled Depreciation | 112,000USD | 238,000USD | 477,000USD | -205,000USD | 551,301USD | 298,057USD | 387,321USD | 302,369USD |
| Total Other Income Expense Net | 5,715,000USD | 8,113,000USD | 7,482,000USD | 2,830,000USD | -176,000USD | 11,171,287USD | 886,304USD | -2,486,536USD |
| Unclassified Operating Expenses | — | — | 12,419,000USD | — | 11,369,718USD | -33,509,318USD | — | — |
| Net Income Applicable To Common Shares | — | — | — | -84,713,000USD | -97,090,824USD | -49,044,477USD | -20,973,056USD | -42,478,952USD |
| Selling And Marketing Expenses | — | — | — | — | 282USD | — | — | — |
| Non Operating Income Net Other | — | — | — | — | -171,127USD | 346,661USD | 888,548USD | -2,189,446USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 527,212,000USD | 335,630,000USD | 279,929,000USD | 218,447,000USD | 190,350,000USD | 157,263,000USD | 139,306,000USD | 147,864,000USD |
| Cash And Equivalents | 63,008,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 326,281,000USD | 331,540,000USD | 273,456,000USD | 210,776,000USD | 183,105,000USD | 149,826,000USD | 131,891,000USD | 139,380,000USD |
| Short Term Investments | 263,273,000USD | 233,939,000USD | 229,696,000USD | 149,540,000USD | 0USD | 100,722,000USD | 94,965,000USD | 107,906,000USD |
| Total Current Assets | 334,815,000USD | 334,676,000USD | 278,192,000USD | 216,615,000USD | 188,422,000USD | 155,262,000USD | 137,254,000USD | 145,759,000USD |
| Other Current Assets | 5,151,000USD | 1,471,000USD | 3,517,000USD | 5,694,000USD | 4,439,000USD | 2,972,000USD | 2,246,000USD | 3,039,000USD |
| Other Non Current Assets | 90,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 53,004,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 12,501,000USD | 11,323,000USD | 14,997,000USD | 12,606,000USD | 9,220,000USD | 9,798,000USD | 10,468,000USD | 8,638,000USD |
| Other Non Current Liabilities | 5,761,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 474,208,000USD | 283,987,000USD | 224,892,000USD | 185,601,000USD | 161,367,000USD | 142,162,000USD | 123,508,000USD | 133,377,000USD |
| Total Equity Including Noncontrolling Interest | 474,208,000USD | — | — | — | — | — | — | — |
| Long Term Debt | 34,742,000USD | 34,505,000USD | 34,287,000USD | 14,445,000USD | 14,332,000USD | — | — | — |
| Net Receivables | 3,341,000USD | 1,665,000USD | 1,219,000USD | 145,000USD | 878,000USD | 2,464,000USD | 3,117,000USD | 3,340,000USD |
| Property Plant Equipment Net | 60,000USD | 208,000USD | 312,000USD | 1,832,000USD | 364,000USD | 384,000USD | 413,000USD | 446,000USD |
| Accounts Payable | 1,272,000USD | 1,530,000USD | 2,717,000USD | 4,804,000USD | 851,000USD | 1,077,000USD | 211,000USD | 1,133,000USD |
| Short Term Debt | 274,000USD | 265,000USD | 256,000USD | 247,000USD | 239,000USD | 245,000USD | 279,000USD | 313,000USD |
| Common Stock | 19,000USD | 13,000USD | 11,000USD | 10,000USD | 9,000USD | 8,000USD | 7,000USD | 7,000USD |
| Retained Earnings | -694,871,000USD | -672,046,000USD | -649,483,000USD | -622,125,000USD | -603,111,000USD | -580,965,000USD | -561,390,000USD | -538,210,000USD |
| Accumulated Other Comprehensive Income | -6,038,000USD | -5,224,000USD | -4,928,000USD | -5,015,999USD | -5,039,000USD | -5,003,000USD | -4,973,000USD | -4,845,000USD |
| Total Liab | — | 51,643,000USD | 55,037,000USD | 32,846,000USD | 28,983,000USD | 15,101,000USD | 15,798,000USD | 14,487,000USD |
| Other Current Liab | — | 9,528,000USD | 12,024,000USD | 7,555,000USD | 8,130,000USD | 8,476,000USD | 9,978,000USD | 7,192,000USD |
| Capital Stock | — | 13,000USD | 11,000USD | 10,000USD | 9,000USD | 8,000USD | 7,000USD | 7,000USD |
| Cash | — | 97,601,000USD | 43,760,000USD | 61,236,000USD | 183,105,000USD | 49,104,000USD | 36,926,000USD | 31,474,000USD |
| Net Debt | — | -61,754,000USD | -8,072,000USD | -45,331,000USD | -167,256,000USD | -47,517,000USD | -35,245,000USD | -29,701,000USD |
| Short Long Term Debt Total | — | 35,847,000USD | 35,688,000USD | 15,905,000USD | 15,849,000USD | 1,587,000USD | 1,681,000USD | 1,773,000USD |
| Property Plant Equipment Gross | — | 208,000USD | 2,637,000USD | 337,000USD | — | — | 2,626,000USD | — |
| Common Stock Shares Outstanding | — | 124,461,818shares | 100,613,438shares | 89,418,028shares | 81,477,548shares | 75,547,746shares | 71,260,875shares | 71,084,787shares |
| Non Current Assets Total | — | 954,000USD | 1,737,000USD | 1,832,000USD | 1,928,000USD | 2,001,000USD | 2,052,000USD | 2,105,000USD |
| Non Current Liabilities Total | — | 40,320,000USD | 40,040,000USD | 20,240,000USD | 19,763,000USD | 5,303,000USD | 5,330,000USD | 5,849,000USD |
| Non Current Liabilities Other | — | 4,591,000USD | 4,448,000USD | 4,582,000USD | 4,153,000USD | 3,961,000USD | 3,928,000USD | 4,389,000USD |
| Non Currrent Assets Other | — | 746,000USD | 1,425,000USD | 1,595,000USD | 1,564,000USD | 1,617,000USD | 1,639,000USD | 1,659,000USD |
| Net Working Capital | — | 323,353,000USD | 263,195,000USD | 204,009,000USD | 179,202,000USD | 145,464,000USD | 126,786,000USD | 137,121,000USD |
| Unclassified Non Current Liabilities | — | 1,224,000USD | 1,305,000USD | 1,213,000USD | 1,278,000USD | 1,342,000USD | 1,402,000USD | 1,460,000USD |
| Unclassified Equity | — | 961,231,000USD | 879,281,000USD | 812,721,999USD | 769,499,000USD | 728,114,000USD | 689,857,000USD | 676,418,000USD |
| Unclassified Non Current Assets | — | — | — | -1,595,000USD | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | 15,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 279,929,000USD | 139,306,000USD | 210,640,000USD | 206,928,000USD | 218,864,844USD | 245,115,213USD | 54,058,020USD | 54,750,542USD |
| Other Current Assets | 2,999,000USD | 2,246,000USD | 6,958,000USD | 5,392,000USD | 13,396,503,000USD | 1,960,849,000USD | 504,402,000USD | 1,182,510USD |
| Total Liab | 55,037,000USD | 15,798,000USD | 16,541,000USD | 21,635,000USD | 19,730,133USD | 19,238,890USD | 8,537,874USD | 6,437,976USD |
| Total Stockholder Equity | 224,892,000USD | 123,508,000USD | 194,099,000USD | 185,293,000USD | 199,134,711USD | 225,876,323USD | 45,520,146USD | 48,312,566USD |
| Other Current Liab | 12,024,000USD | 9,978,000USD | 9,577,000USD | 10,629,000USD | 6,090,000USD | 11,031,685USD | 3,583,755USD | 4,063,196USD |
| Common Stock | 11,000USD | 7,000USD | 7,000USD | 5,000USD | 4,090USD | 3,697USD | 1,508USD | 876USD |
| Capital Stock | 11,000USD | 7,000USD | 7,000USD | 5,000USD | 4,090USD | 3,697USD | 1,508USD | 876USD |
| Retained Earnings | -649,483,000USD | -561,390,000USD | -466,331,000USD | -377,884,000USD | -293,171,423USD | -186,420,599USD | -137,376,122USD | -116,855,991USD |
| Cash | 43,760,000USD | 36,926,000USD | 135,117,000USD | 111,097,000USD | 190,300,776USD | 115,917,807USD | 8,962,686USD | 33,718,713USD |
| Cash And Short Term Investments | 273,456,000USD | 131,891,000USD | 197,815,000USD | 184,880,000USD | 190,300,776USD | 215,923,365USD | 37,240,072USD | 33,718,713USD |
| Total Current Assets | 278,192,000USD | 137,254,000USD | 209,626,000USD | 192,813,000USD | 204,126,115USD | 230,257,209USD | 39,394,749USD | 39,372,134USD |
| Total Current Liabilities | 14,997,000USD | 10,468,000USD | 12,143,000USD | 17,054,000USD | 18,275,930USD | 12,020,447USD | 3,922,999USD | 4,527,405USD |
| Net Debt | -8,072,000USD | -35,245,000USD | -134,446,000USD | -109,973,000USD | -188,765,664USD | -114,092,967USD | -7,218,558USD | -33,145,943USD |
| Short Term Debt | 256,000USD | 279,000USD | 496,000USD | 452,000USD | 411,450USD | 356,716USD | 259,449USD | 71,596USD |
| Short Long Term Debt Total | 35,688,000USD | 1,681,000USD | 671,000USD | 1,124,000USD | 1,865,653USD | 2,185,159USD | 2,124,324USD | 1,923,667USD |
| Long Term Debt | 34,287,000USD | — | — | — | 1,454,203USD | 1,828,443USD | 1,864,875USD | 1,852,071USD |
| Short Term Investments | 229,696,000USD | 94,965,000USD | 62,698,000USD | 73,783,000USD | 0USD | 100,005,558USD | 28,277,386USD | — |
| Net Receivables | 1,737,000USD | 3,117,000USD | 4,853,000USD | 2,541,000USD | 5,838,475USD | 12,372,995USD | 1,650,275USD | 4,470,911USD |
| Accounts Payable | 2,717,000USD | 211,000USD | 2,070,000USD | 4,804,000USD | 2,034,493USD | 612,293USD | 18,232USD | 372,860USD |
| Property Plant Equipment Net | 312,000USD | 413,000USD | 651,000USD | 1,081,000USD | 1,447,786USD | 1,960,745USD | 1,802,529USD | 1,342,802USD |
| Property Plant Equipment Gross | 2,637,000USD | 2,626,000USD | 2,626,000USD | 2,579,000USD | 1,447,786USD | 1,960,745USD | 1,802,529USD | 1,342,802USD |
| Accumulated Other Comprehensive Income | -4,928,000USD | -4,973,000USD | -5,004,000USD | -5,227,000USD | -5,040,163USD | -5,044,517USD | -5,020,156USD | -5,040,163USD |
| Common Stock Shares Outstanding | 88,104,132shares | 71,003,399shares | 53,246,937shares | 46,926,349shares | 41,283,498shares | 25,637,023shares | 13,124,951shares | 2,802,382shares |
| Non Current Assets Total | 1,737,000USD | 2,052,000USD | 1,014,000USD | 14,115,000USD | 14,738,729USD | 14,858,004USD | 14,663,271USD | 15,378,408USD |
| Non Current Liabilities Total | 40,040,000USD | 5,330,000USD | 4,398,000USD | 4,581,000USD | 1,454,203USD | 7,218,443USD | 4,614,875USD | 1,910,571USD |
| Non Current Liabilities Other | 4,448,000USD | 3,928,000USD | 4,223,000USD | 3,909,000USD | 1,454,203USD | 5,390,000USD | 2,750,000USD | 240,090USD |
| Non Currrent Assets Other | 1,425,000USD | 1,639,000USD | 363,000USD | 615,000USD | 871,976USD | 73,413USD | 128,547USD | 183,682USD |
| Net Working Capital | 263,195,000USD | 126,786,000USD | 197,483,000USD | 175,759,000USD | 185,850,185USD | 218,236,762USD | 35,471,750USD | 34,844,729USD |
| Unclassified Non Current Liabilities | 1,305,000USD | 1,402,000USD | — | -3,237,000USD | -1,784,744USD | -7,218,443USD | -3,130,196USD | -1,649,487USD |
| Unclassified Equity | 879,281,000USD | 689,857,000USD | 665,420,000USD | 568,394,000USD | 497,338,117USD | 417,334,045USD | 187,913,408USD | 170,206,968USD |
| Other Assets | — | — | 1USD | 19,000USD | 73,798USD | 977,238USD | 128,547USD | 183,682USD |
| Current Deferred Revenue | — | — | 1USD | — | 9,739,987USD | 19,753USD | 61,563USD | 19,753USD |
| Intangible Assets | — | — | — | 12,419,000USD | 12,418,967USD | 12,823,846USD | 12,732,195USD | 13,851,924USD |
| Other Liab | — | — | — | 3,909,000USD | 330,541USD | 7,218,443USD | 3,130,196USD | 1,409,397USD |
| Inventory | — | — | — | 34,000USD | -13,388,516,136USD | -1,958,888,151USD | -503,897,598USD | — |
| Net Tangible Assets | — | — | — | 172,874,000USD | 186,715,744USD | 213,052,477USD | 32,787,951USD | 34,460,642USD |
| Unclassified Current Liabilities | — | — | — | 1,169,000USD | — | — | — | — |
| Unclassified Current Assets | — | — | — | — | -13,388,516,136USD | -1,958,888,151USD | -503,897,598USD | — |
| Deferred Long Term Liab | — | — | — | — | — | — | — | 58,500USD |
| Short Long Term Debt | — | — | — | — | — | — | — | 71,596USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -22,563,000USD | -27,358,000USD | -19,014,000USD | -22,146,000USD | -19,575,000USD | -23,180,000USD | -22,845,000USD | -24,640,000USD |
| Depreciation | 23,000USD | 26,000USD | 27,000USD | 30,000USD | 29,000USD | 33,000USD | 37,000USD | 61,000USD |
| Stock Based Compensation | 3,378,000USD | 4,941,000USD | 3,554,000USD | 3,566,000USD | 4,015,000USD | 3,354,000USD | 3,078,000USD | 4,311,000USD |
| Other Non Cash Items | 3,589,000USD | -675,000USD | 3,000USD | 2,940,000USD | -701,000USD | -936,000USD | 1,023,000USD | -996,000USD |
| Change To Account Receivables | 72,000USD | -345,000USD | -514,000USD | 1,586,000USD | 1,334,000USD | 223,000USD | -1,158,000USD | -433,000USD |
| Change In Working Capital | -1,991,000USD | 3,618,000USD | 3,533,000USD | -472,000USD | 73,000USD | 2,464,000USD | -8,411,000USD | 3,156,000USD |
| Total Cash From Operating Activities | -20,942,000USD | -19,448,000USD | -11,897,000USD | -19,648,000USD | -16,840,000USD | -18,265,000USD | -27,118,000USD | -18,108,000USD |
| Capital Expenditures | -21,000USD | -1,000USD | 0USD | -10,000USD | 0USD | 0USD | 0USD | 0USD |
| Free Cash Flow | -20,963,000USD | -19,449,000USD | -11,897,000USD | -19,658,000USD | -16,840,000USD | -18,265,000USD | -27,118,000USD | -18,108,000USD |
| Investments | -3,669,000USD | -79,157,000USD | -149,321,000USD | 101,107,000USD | -5,101,000USD | 13,632,000USD | 1,199,000USD | -3,696,000USD |
| Total Cashflows From Investing Activities | -3,690,000USD | -79,158,000USD | -149,321,000USD | 101,107,000USD | -5,101,000USD | 13,632,000USD | 1,199,000USD | -3,696,000USD |
| Total Cash From Financing Activities | 78,473,000USD | 81,130,000USD | 39,349,000USD | 52,542,000USD | 34,119,000USD | 10,085,000USD | 266,000USD | -46,000USD |
| Sale Purchase Of Stock | 177,000USD | — | 121,000USD | — | 170,000USD | — | 1,144,000USD | -244,000USD |
| Issuance Of Capital Stock | 79,257,000USD | 61,354,000USD | 39,638,000USD | 37,823,000USD | 34,918,000USD | 9,694,000USD | 131,000USD | 0USD |
| Change In Cash | 53,841,000USD | -17,476,000USD | -121,869,000USD | 134,001,000USD | 12,178,000USD | 5,452,000USD | -25,653,000USD | -21,850,000USD |
| Begin Period Cash Flow | 43,802,000USD | 61,278,000USD | 183,147,000USD | 49,146,000USD | 36,968,000USD | 31,516,000USD | 57,169,000USD | 79,019,000USD |
| End Period Cash Flow | 97,643,000USD | 43,802,000USD | 61,278,000USD | 183,147,000USD | 49,146,000USD | 36,968,000USD | 31,516,000USD | 57,169,000USD |
| Other Cashflows From Financing Activities | -695,000USD | 273,000USD | -289,000USD | -6,000USD | -799,000USD | 391,000USD | 135,000USD | -244,000USD |
| Unclassified Operating Cash Flow | -3,378,000USD | — | — | -3,566,000USD | — | — | — | — |
| Unclassified Financing Cash Flow | 78,991,000USD | — | 39,517,000USD | 14,725,000USD | 34,748,000USD | — | -1,013,000USD | — |
| Net Borrowings | — | 20,000,000USD | 0USD | — | — | — | 0USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -88,093,000USD | -95,059,000USD | -88,447,000USD | -84,713,000USD | -97,090,000USD | -49,044,477USD | -20,520,131USD | -39,171,152USD |
| Depreciation | 112,000USD | 238,000USD | 477,000USD | 493,000USD | 551,000USD | 298,057USD | 387,321USD | 302,369USD |
| Stock Based Compensation | 16,076,000USD | 14,393,000USD | 10,640,000USD | 8,101,000USD | 5,519,000USD | 2,576,006USD | 1,264,231USD | 773,248USD |
| Other Non Cash Items | -1,701,000USD | -3,898,000USD | 9,794,000USD | -578,000USD | 13,033,000USD | 16,265,010USD | 7,505,724USD | 27,876,227USD |
| Change To Account Receivables | 2,061,000USD | 1,736,000USD | -2,312,000USD | 3,298,000USD | 6,534,000USD | -3,589,024USD | 2,440,759USD | 344,301USD |
| Change In Working Capital | 6,752,000USD | 4,478,000USD | -8,274,000USD | 14,111,000USD | -251,000USD | -4,512,159USD | 1,819,358USD | 6,980,194USD |
| Total Cash From Operating Activities | -67,535,000USD | -79,848,000USD | -75,810,000USD | -62,586,000USD | -78,238,000USD | -34,436,636USD | -9,601,997USD | -9,388,908USD |
| Capital Expenditures | -11,000USD | 0USD | -47,000USD | -126,000USD | -12,312,000USD | -342,421USD | -28,999USD | -1,015,634USD |
| Free Cash Flow | -67,546,000USD | -79,848,000USD | -75,857,000USD | -62,712,000USD | -90,550,000USD | -34,779,057USD | -9,630,996USD | -10,404,542USD |
| Investments | -132,462,000USD | -28,386,000USD | 13,732,000USD | -73,399,000USD | 99,834,776USD | -71,752,534USD | -28,257,379USD | -1,001,142USD |
| Total Cashflows From Investing Activities | -132,473,000USD | -28,386,000USD | 13,732,000USD | -73,399,000USD | 87,523,000USD | -72,094,955USD | -28,286,378USD | -1,001,142USD |
| Net Borrowings | 35,000,000USD | 0USD | — | — | 0USD | — | -292,002USD | -1,549,702USD |
| Total Cash From Financing Activities | 206,842,000USD | 10,044,000USD | 86,105,000USD | 56,781,000USD | 65,098,000USD | 213,486,712USD | 12,532,106USD | 32,489,905USD |
| Sale Purchase Of Stock | 291,000USD | 300,000USD | 215,000USD | -516,000USD | 224,472,000USD | 135,471,000USD | 3,791,485,000USD | -2,386,285USD |
| Issuance Of Capital Stock | 173,733,000USD | 9,994,000USD | 86,816,000USD | 56,347,000USD | 65,039,851USD | 172,319,358USD | 12,668,784USD | 37,402,994USD |
| Change In Cash | 6,834,000USD | -98,190,000USD | 24,027,000USD | -79,204,000USD | 74,383,000USD | 106,955,121USD | -25,356,269USD | 22,049,490USD |
| Begin Period Cash Flow | 36,968,000USD | 135,158,000USD | 111,131,000USD | 190,335,000USD | 115,952,000USD | 8,996,860USD | 34,353,129USD | 12,303,639USD |
| End Period Cash Flow | 43,802,000USD | 36,968,000USD | 135,158,000USD | 111,131,000USD | 190,335,000USD | 115,951,981USD | 8,996,860USD | 34,353,129USD |
| Other Cashflows From Financing Activities | -709,000USD | 50,000USD | -496,000USD | 434,000USD | 58,000USD | 41,799,354USD | 155,324USD | -3,363,387USD |
| Unclassified Financing Cash Flow | 172,260,000USD | 9,694,000USD | 86,386,000USD | 56,863,000USD | -159,432,000USD | 171,687,358USD | 12,668,784USD | 39,812,177USD |
| Change To Inventory | — | — | 1USD | — | — | — | -288,805USD | 5,593,718USD |
| Change To Liabilities | — | — | — | 2,770,000USD | -877,168USD | 7,581,875USD | -1,156,311USD | 260,172USD |
| Other Cashflows From Investing Activities | — | — | — | -73,273,000USD | -195,000USD | -138,464USD | -27,772USD | 14,492USD |
| Unclassified Investing Cash Flow | — | — | — | 73,399,000USD | — | — | — | 1,001,142USD |
| Cash And Cash Equivalents Changes | — | — | — | — | 74,382,969USD | 106,955,121USD | -25,356,269USD | 22,099,855USD |
| Dividends Paid | — | — | — | — | — | -135,471,000USD | -3,791,485,000USD | -22,898USD |
| Unclassified Operating Cash Flow | — | — | — | — | — | — | — | -6,149,794USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| FY 2018Yearly · 2018-12-31 | Product | Grant | 10,311,388 | USD | 0001564590-19-010429 |
| FY 2018Yearly · 2018-12-31 | Product | License And Service | 19,780 | USD | 0001564590-19-010429 |
| Q3 2018Quarterly · 2018-09-30 | Product | Grant | 2,629,446 | USD | 0001193125-18-325587 |
| Q3 2018Quarterly · 2018-09-30 | Product | License And Service | 4,947 | USD | 0001193125-18-325587 |
| Q2 2018Quarterly · 2018-06-30 | Product | Grant | 2,412,193 | USD | 0001193125-18-248492 |
| Q2 2018Quarterly · 2018-06-30 | Product | License And Service | 4,947 | USD | 0001193125-18-248492 |
| FY 2017Yearly · 2017-12-31 | Product | Grant | 10,696,819 | USD | 0001564590-19-010429 |
| FY 2017Yearly · 2017-12-31 | Product | License And Service | 41,503 | USD | 0001564590-19-010429 |
| Q3 2017Quarterly · 2017-09-30 | Product | Grant | 4,565,251 | USD | 0001193125-18-325587 |
| Q3 2017Quarterly · 2017-09-30 | Product | License And Service | 26,689 | USD | 0001193125-18-325587 |
| Q2 2017Quarterly · 2017-06-30 | Product | Grant | 3,033,035 | USD | 0001193125-18-248492 |
| Q2 2017Quarterly · 2017-06-30 | Product | License And Service | 4,938 | USD | 0001193125-18-248492 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.